MHC Class I-Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses Against Breast and Ovarian Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-2614
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Developmentally Restricted Differentiation Antigens Are Targets for Immunotherapy in Epithelial Ovarian Carcinoma

International Journal of Gynecological Pathology
GynecologyForensic MedicinePathologyObstetrics
2013English

Tumor Infiltrating Lymphocyte Therapy for Ovarian Cancer and Renal Cell Carcinoma

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Breast Cancer Following Ovarian Cancer inBRCAMutation Carriers

JAMA Surgery
Surgery
2014English

Hereditary Breast and Ovarian Cancer Syndrome

Klinicka Onkologie
Oncology
2016English

Understanding Hereditary Breast and Ovarian Cancer

Clinical Journal of Oncology Nursing
Oncology
2003English

Hormone-Receptor Expression and Ovarian Cancer Survival: An Ovarian Tumor Tissue Analysis Consortium Study

The Lancet Oncology
Oncology
2013English

Thailandepsins Are New Small Molecule Class I HDAC Inhibitors With Potent Cytotoxic Activity in Ovarian Cancer Cells: A Preclinical Study of Epigenetic Ovarian Cancer Therapy

Journal of Ovarian Research
GynecologyOncologyObstetrics
2012English

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

Hereditary Breast-Ovarian Cancer Syndrome in Russia

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy